Eikon Therapeutics Inc. (EIKN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Eikon Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$5.54
−0.09% today
Market cap
$300M
Overall quality
48/100
Kronos AI 30-day
+83.6%
8 of 8 simulated paths end higher
Eikon Therapeutics Inc. (EIKN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $300M. It trades at $5.54, down 0.09% today. Its overall quality score is 48 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +83.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $10.19 (+83.6%) |
| Likely range | +71.7% … +93.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 57 |
| Growth | 38 |
| Overall | 48 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.